Stock listing
NASDAQ:HLXC Helix Acquisition Corp. III Stock
Home listing (NASDAQ) of Helix Acquisition Corp. III
Follow Helix Acquisition Corp. III into a list and get an email when it puts out news.
Share price · NASDAQ:HLXC
$10.23 USD -0.08 (-0.8%)
Close on Nov 20, 2026
- Day range
- $10.22 – $10.27 USDNov 20, 2026
- Volume
- 12,394 sharesNov 20, 2026
- Market cap
- $181.6M USDAt the close on Nov 20, 2026 · price × 17.75M shares outstanding
- Traded on an average day
- $377,767 USDMedian day 2,343 shares · 10 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HLXC · Home | $10.23 USD | -0.08 (-0.8%) | 12,394 | $10.25 | $10.27 | $10.22 | $10.31 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HLXC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.23 | -0.08 | -0.8% | $10.25 | $10.27 | $10.22 | 12,394 | |
| $10.31 | +0.03 | +0.3% | $10.31 | $10.31 | $10.31 | 359 | |
| $10.28 | 0.00 | 0.0% | $10.32 | $10.32 | $10.27 | 14 | |
| $10.28 | -0.01 | -0.1% | $10.32 | $10.32 | $10.27 | 24,411 | |
| $10.29 | +0.01 | +0.1% | $10.29 | $10.29 | $10.29 | 1,417 | |
| $10.28 | 0.00 | 0.0% | $10.27 | $10.28 | $10.27 | 13 | |
| $10.28 | 0.00 | 0.0% | $10.27 | $10.28 | $10.27 | 788 | |
| $10.28 | 0.00 | 0.0% | $10.27 | $10.29 | $10.27 | 87,362 | |
| $10.28 | -0.02 | -0.2% | $10.27 | $10.28 | $10.25 | 33,078 | |
| $10.30 | +0.01 | +0.1% | $10.27 | $10.30 | $10.27 | 184,973 | |
| $10.29 | -0.01 | -0.1% | $10.30 | $10.30 | $10.27 | 32,912 | |
| $10.30 | -0.01 | -0.1% | $10.30 | $10.30 | $10.30 | 556 | |
| $10.31 | 0.00 | 0.0% | $10.30 | $10.31 | $10.30 | 6,212 | |
| $10.31 | +0.04 | +0.4% | $10.30 | $10.31 | $10.30 | 6,318 | |
| $10.27 | -0.025 | -0.2% | $10.29 | $10.29 | $10.27 | 2,487 | |
| $10.30 | -0.015 | -0.1% | $10.30 | $10.30 | $10.30 | 166 | |
| $10.31 | +0.02 | +0.2% | $10.30 | $10.31 | $10.29 | 22,831 | |
| $10.29 | -0.01 | -0.1% | $10.31 | $10.31 | $10.29 | 68,887 | |
| $10.30 | +0.05 | +0.5% | $10.26 | $10.30 | $10.25 | 57,744 | |
| $10.25 | +0.03 | +0.3% | $10.20 | $10.28 | $10.20 | 168,135 | |
| $10.22 | -0.01 | -0.1% | $10.30 | $10.30 | $10.15 | 327,323 | |
| $10.23 | -0.09 | -0.9% | $10.34 | $10.34 | $10.23 | 16,513 | |
| $10.32 | -0.01 | -0.1% | $10.33 | $10.38 | $10.32 | 2,199 | |
| $10.33 | -0.07 | -0.7% | $10.43 | $10.43 | $10.33 | 3,400 | |
| $10.40 | 0.00 | 0.0% | $10.40 | $10.40 | $10.40 | 17 | |
| $10.40 | -0.09 | -0.9% | $10.44 | $10.44 | $10.35 | 227,000 | |
| $10.49 | -0.01 | -0.1% | $10.36 | $10.49 | $10.35 | 2,800 | |
| $10.50 | 0.00 | 0.0% | $10.50 | $10.50 | $10.50 | 0 | |
| $10.50 | 0.00 | 0.0% | $10.36 | $10.50 | $10.36 | 300 | |
| $10.50 | +0.02 | +0.2% | $10.47 | $10.50 | $10.46 | 3,300 | |
| $10.48 | -0.06 | -0.6% | $10.48 | $10.48 | $10.48 | 300 | |
| $10.54 | -0.03 | -0.3% | $10.51 | $10.60 | $10.47 | 52,100 | |
| $10.57 | 0.00 | 0.0% | $10.57 | $10.57 | $10.57 | 40 | |
| $10.57 | -0.05 | -0.5% | $10.60 | $10.60 | $10.52 | 900 | |
| $10.62 | 0.00 | 0.0% | $10.62 | $10.62 | $10.62 | 37 | |
| $10.62 | -0.12 | -1.1% | $10.60 | $10.68 | $10.50 | 38,600 | |
| $10.74 | -0.01 | -0.1% | $10.55 | $10.74 | $10.53 | 10,611 | |
| $10.75 | -0.19 | -1.7% | $10.59 | $10.90 | $10.55 | 27,977 | |
| $10.94 | 0.00 | 0.0% | $10.94 | $10.94 | $10.94 | 25 | |
| $10.94 | +0.17 | +1.6% | $10.61 | $10.94 | $10.50 | 631,300 | |
| $10.77 | +0.17 | +1.6% | $10.70 | $10.88 | $10.70 | 6,800 | |
| $10.60 | 0.00 | 0.0% | $10.60 | $10.60 | $10.60 | 3,000 | |
| $10.60 | 0.00 | 0.0% | $10.60 | $10.60 | $10.60 | 0 | |
| $10.60 | -0.10 | -0.9% | $10.60 | $10.60 | $10.59 | 113,200 | |
| $10.70 | -0.10 | -0.9% | $10.51 | $10.79 | $10.35 | 8,700 | |
| $10.80 | 0.00 | 0.0% | $10.80 | $10.80 | $10.80 | 0 | |
| $10.80 | 0.00 | 0.0% | $10.80 | $10.80 | $10.80 | 0 | |
| $10.80 | 0.00 | 0.0% | $10.80 | $10.80 | $10.80 | 0 | |
| $10.80 | 0.00 | 0.0% | $10.80 | $10.80 | $10.80 | 0 | |
| $10.80 | 0.00 | 0.0% | $10.65 | $10.80 | $10.64 | 4,000 | |
| $10.80 | +0.156 | +1.5% | $10.75 | $10.80 | $10.75 | 1,800 | |
| $10.64 | -0.055 | -0.5% | $10.65 | $10.65 | $10.64 | 1,100 | |
| $10.70 | -0.051 | -0.5% | $10.65 | $10.70 | $10.65 | 700 | |
| $10.75 | 0.00 | 0.0% | $10.75 | $10.75 | $10.75 | 0 | |
| $10.75 | 0.00 | 0.0% | $10.80 | $10.80 | $10.75 | 1,600 | |
| $10.75 | 0.00 | 0.0% | $10.75 | $10.75 | $10.75 | 0 | |
| $10.75 | -0.025 | -0.2% | $10.95 | $11.05 | $10.70 | 58,400 | |
| $10.78 | -0.13 | -1.2% | $10.78 | $10.78 | $10.78 | 200 | |
| $10.91 | -0.015 | -0.1% | $10.60 | $10.91 | $10.60 | 500 | |
| $10.92 | -0.005 | 0.0% | $10.75 | $10.92 | $10.75 | 600 | |
| $10.93 | 0.00 | 0.0% | $10.93 | $10.93 | $10.93 | 0 | |
| $10.93 | 0.00 | 0.0% | $10.93 | $10.93 | $10.93 | 0 | |
| $10.93 | +0.075 | +0.7% | $10.85 | $10.99 | $10.60 | 30,600 | |
| $10.85 | -0.06 | -0.5% | $10.85 | $10.89 | $10.78 | 9,100 |
- Ticker
- NASDAQ:HLXC
- Asset type
- Stock
- Sector
- Financials
- Industry
- Shell companies & SPACs
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares
Jan 27, 2026
Closed $10.25 (+0.3%) on Jan 27, 2026
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering
Jan 23, 2026
Closed $10.25 (+2.5%) on Jan 23, 2026
Helix Acquisition Corp. III on 6ix
- Sector
- Financials
- Industry
- Shell companies & SPACs
- News releases
- 2 in the last 12 months · 2 in all · newest Jan 27, 2026 · oldest 2026
Where Helix Acquisition Corp. III is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HLXC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:HLXC | BOATS | United States | USD |
Valuation
balance Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $179.4M USD
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.04
Shell companies & SPACs: the 10 companies nearest in size, of 284 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Helix Acquisition Corp. III · NASDAQ:HLXC | US$181.6M | US$179.4M | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 |
| Solarius Capital Acquisition Corp. · NASDAQ:SOCA | US$185.7M | US$185.0M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Invest Green Acquisition Corporation · NASDAQ:IGAC | US$183.9M | US$183.3M | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 |
| McKinley Acquisition Corporation · NASDAQ:MKLY | US$183.7M | US$183.3M | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 |
| Tailwind 2.0 Acquisition Corp. · NASDAQ:TDWD | US$182.2M | US$181.6M | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 |
| Digital Asset Acquisition Corp. · NASDAQ:DAAQ | US$181.6M | US$181.5M | 34.8× | n/a | n/a | n/a | n/a | n/a | 0.39 |
| ARC Group Acquisition I Corp · NASDAQ:ARCL | US$180.0M | US$179.1M | n/a | n/a | n/a | 255× | n/a | 0.0× | n/a |
| Apogee Acquisition Corp · NASDAQ:AACP | US$179.9M | US$179.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Twelve Seas Investment Company III · NASDAQ:TWLV | US$179.8M | US$179.5M | 41.0× | n/a | n/a | n/a | n/a | n/a | 0.01 |
| SPACSphere Acquisition Corp. · NASDAQ:SSAC | US$179.1M | US$3.99M | 146× | n/a | n/a | 1.1× | n/a | 0.0× | 0.00 |
| Proem Acquisition Corp I · NASDAQ:PAAC | US$178.1M | US$177.6M | n/a | n/a | n/a | n/a | n/a | n/a | -0.02 |
| Median of the others | US$180.8M | US$180.5M | 41.0× | 128× | 0.0× | 0.01 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to May 31, 2026 | Jun 30, 2026 | +0.2% |
| Quarter to Feb 28, 2026 | Mar 31, 2026 | −0.9% |
Financings
| Raise | Date |
|---|---|
| Public offering of class A ordinary shares Closed: US$172.5M raised · US$10 a share · Leerink Partners +1 Dealers: Leerink Partners (co-lead), Oppenheimer & Co. (co-lead) | Jan 27, 2026 |
| Private placement of class A ordinary shares Closed: US$4.97M raised · US$10 a share Buyers: Helix Holdings III LLC (497,500 Class A ordinary shares for $4,975,000) Insiders: Sold to the company's sponsor, Helix Holdings III LLC | Jan 27, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
A blank check company (SPAC). Priced at US$10.00 a share on Jan 22, 2026.
- Price
- US$10.00 a share
- Shares offered
- 15,000,000 Class A ordinary shares
- Offering size
- US$150 million
- Underwriters' option
- Up to 2,250,000 more shares
- Listing
- HLXC on the Nasdaq Global Market
- Underwriters
- Leerink Partners, Oppenheimer & Co. · In the order on the cover
- Shares delivered
- On or about Jan 26, 2026
Steps
| Step | When |
|---|---|
| Filed publicly | Dec 8, 2025 |
| Amended once | Jan 16, 2026 |
| Shares registered with an exchange | Jan 22, 2026 |
| Declared effective by the SEC | Jan 22, 2026 |
| Final prospectus, with the price | Jan 23, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 23, 2026 |
| EFFECT · Notice that a registration is effective | Jan 22, 2026 |
| S-1MEF · Registration of more shares for the same offering | Jan 22, 2026 |
| CERT · Exchange's certificate of listing | Jan 22, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 22, 2026 |
| CORRESP · Letter to the SEC | Jan 20, 2026 |
| CORRESP · Letter to the SEC | Jan 20, 2026 |
| S-1/A · Registration statement, amended | Jan 16, 2026 |
| UPLOAD · Letter from the SEC | Jan 14, 2026 |
| S-1 · Registration statement | Dec 8, 2025 |
Open IPO · From the cover of the final prospectus (424B4) filed Jan 23, 2026
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 13, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 17, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | May 15, 2026 | Big-stake notice | SEC |
All 39 filings
Cap table
Built by 6ix from Helix Acquisition Corp. III’s releases · as of Jan 27, 2026
- Common shares
- 17,747,500
- Fully diluted
- 17,747,500
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 17,747,500 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 17,747,500 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bihua Chen Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past) | Chairperson and CEO, Director · Since at least Jan 22, 2026 |
| John Schmid Other companies: BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past) | Director · Since at least Jan 22, 2026 |
| Mark McKenna Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Jul 16, 2024); Spyre Therapeutics, Inc. (Board Member · Since at least Feb 1, 2024); Apogee Therapeutics, Inc. (Director · Since at least Aug 17, 2023); Freenome, Inc. (Director · Jun 11, 2024 – Jun 11, 2024 · Past); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Prometheus Biosciences Inc (Chairman, President and CEO, Director · Mar 11, 2021 – Jun 16, 2023 · Past); Bausch Health Companies Inc. (President, Salix · Aug 2, 2018 – Aug 19, 2019 · Past) | Director · Since at least Jan 22, 2026 |
| Caleb Tripp Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Financial Officer · Since at least Feb 8, 2024); BridgeBio Pharma, Inc. (Chief Financial Officer · Feb 28, 2025 – Nov 4, 2026 · Past) | CFO & COO · Since at least Jan 22, 2026 |
| Nebojsa Obradovic Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Legal Officer · Since at least Feb 8, 2024) | Chief Legal Officer · Since at least Jan 22, 2026 |
Log in to ask 6ix AI your own questions about Helix Acquisition Corp. III.